Catalent Inc (NYSE:CTLT)
| 109.61 Delayed Data As of Jun 24 |  0.00 / 0.00%Today’s Change | 86.34 Today|||52-Week Range 142.64 | -14.39% Year-to-Date |
Latest CTLT News | Press Releases
No recent news for Catalent Inc.
Today’s Trading
| Previous close | 109.61 |
| Today’s open | 110.64 |
| Day’s range | 107.69 - 111.12 |
| Volume | 2,365,879 |
| Average volume (3 months) | 1,232,610 |
| Market cap | $18.4B |
Data as of 4:01pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | +172.65% |
| Earnings growth (this year) | +25.05% |
| Earnings growth (next 5 years) | +14.62% |
| Revenue growth (last year) | +29.21% |
| P/E ratio | 39.4 |
| Price/Sales | 4.60 |
| Price/Book | 4.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HZNPHorizon Therapeutics... | +2.20 | +2.65% |
| ALNYAlnylam Pharmaceutic... | +1.21 | +0.83% |
| INCYIncyte Corp | +3.40 | +4.55% |
| VTRSViatris Inc | +0.24 | +2.24% |
Data as of 4:01pm ET, 06/24/2022
Financials
| Next reporting date | August 29, 2022 |
| EPS forecast (this quarter) | $1.15 |
| Annual revenue (last year) | $4.0B |
| Annual profit (last year) | $529.0M |
| Net profit margin | 13.23% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Somerset, New Jersey |
Forecasts
